News
- UK University Hospitals build the NoRCoRP platform
- Scientists tackle vaccine safety, efficacy and access at global R&D forum
- Federal judge enters consent decree against Washington state juice processor
- FDA Warns Firms to Remove Unauthorized E-liquid Products from Market in First Letters Issued to Manufacturers that Did Not Submit Premarket Applications by Deadline
- Family physicians’ crucial role in mental health
- FDA Grants First Conditional Approval Under Expanded Authority to Control Seizures in Dogs with Idiopathic Epilepsy
- Universal health coverage high on the political agenda during the Regional Director’s visit to Georgia
- CBP, FDA Seize Counterfeit, Unauthorized E-Cigarettes
- EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
- FDA Releases Artificial Intelligence/Machine Learning Action Plan
- UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile
- WHO urges governments to promote healthy food in public facilities
- FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs
- Neglected tropical diseases: WHO to formally launch new road map for next decade
- Canadian University initiated COVID-19 Emergency Department Registry
- Research Association conducts clinical trial of Eye Movements Recording Using a Smartphone
- Five million COVID-19 cases reported in WHO's Eastern Mediterranean Region
- FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff
- Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19
- FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines
- Extra dose from vials of Comirnaty COVID-19 vaccine
- EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU
- FDA Takes Steps to Provide Clarity on Developing New Drug Products in the Age of Individualized Medicine
- HHS Announces $22 Billion in Funding to Support Expanded Testing, Vaccination Distribution
- US Institute conducts cclinical trial of Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males
Clinical Research News
Prossimi studi clinici
-
Aperta Biosciences, LLCNon ancora reclutamento
-
Hospices Civils de LyonNon ancora reclutamentoIncontinenza urinaria | Vescica neurogena | Deviazione urinaria | Neoplasia pelvica | Carcinoma della vescica urinariaFrancia
-
Second Affiliated Hospital, Zhejiang University...ReclutamentoUdito normale | Esposizione al rumore | Preferred Loudness LevelCina
-
Qilu Pharmaceutical Co., Ltd.Non ancora reclutamentoCarcinoma a cellule renali a cellule chiare | Cancro ovarico | Altri tumori solidi avanzatiCina
-
University Hospital, AntwerpNon ancora reclutamentoEnterocolite necrotizzante del neonato | Sepsi neonatale ad esordio tardivoBelgio, Olanda
-
VA Office of Research and DevelopmentNon ancora reclutamentoCarcinoma polmonare non a piccole cellule metastatico | Cancer-Associated Weight Loss | Elevated Inflammatory MarkersStati Uniti
-
ENTire Medical Ltd.Non ancora reclutamentoIpertrofia | Tonsillectomia | Ostruzione delle vie aeree superiore | Chirurgia dell'adenoidectomiaStati Uniti
-
AbbVieNon ancora reclutamentoPsoriasi da moderata a grave
-
Institute of Hematology & Blood Diseases Hospital...ReclutamentoAnemia aplastica | Emopoiesi clonale | Terapia immunosoppressivaCina
-
Ahmed Nasser Ali MabkhoutReclutamentoCisti mascellari | Alveolar Bone DefectsYemen
-
University of CoimbraNon ancora reclutamento
-
AbbVieNon ancora reclutamento
